MED: Mediplantex National Pharmaceutical Joint Stock Company - Summary | Jitta

Mediplantex National Pharmaceutical Joint Stock Company

VNM:MED

Price
₫18,400.00
Loss Chance
49.2%
4.02JITTA SCORE
98.54%Over Jitta Line
Jitta Ranking
275 / 637
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (66)
Recent Business Performance (47)
Financial Strength (48)
Return to Shareholders (13)
Competitive Advantage (31)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Debt LevelLow Long Term Debt
Interest Coverage RatioGood
Revenue and EarningRevenue decline from 2022-2025
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
4.02
98.54%
4.23
239.45%
3.86
198.10%
Pharmaceuticals
5.90
76.13%
4.60
125.10%
3.71
> 1,000%
COMPANY DESCRIPTION
Mediplantex National Pharmaceutical Joint Stock Company produces and trades in pharmaceutical products in Vietnam. The company offers pharmaceutical products in various categories, including drugs from herbals; analgesics, corticosteroid, and anti-inflammatory drugs; antibiotics; cerebral circulation, heart, and lung drugs; anti-malarial, demostasis, gout, diabetes, allergies, and osteoarthritis drugs; acid amin, vitamins, and minerals; and other products. It also provides pharmaceutical chemicals and medicinal herbs; and extracting and semi synthetic materials, such as essential oils. In addition, the company engages in the real estate business; export and import of goods; and warehousing and storage activities. Mediplantex National Pharmaceutical Joint Stock Company was incorporated in 2005 and is headquartered in Hanoi, Vietnam.